Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Not applicable Country / region: China Clear all

212 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20061
20071
200811
20093
20102
20116
201210
20138
20144
201513
201610
20178
201812
201911
202020
202118
202213
202314
202421
20259
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status88
Completed63
Recruiting43
Not yet recruiting8
Active, not recruiting5
Terminated4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eastern Hepatobiliary Surgery Hospital26
Sun Yat-sen University25
RenJi Hospital10
Second Affiliated Hospital, Zhejiang University, School of Medicine8
Southwest Hospital, China8
Fudan University7
Zhongda Hospital6
Shanghai Zhongshan Hospital5
Tianjin Medical University Cancer Institute and Hospital5
Chinese PLA General Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular212
Liver Neoplasms16
Recurrence11
Cholangiocarcinoma6
Fibrosis3
Hepatitis B3
Neoplastic Cells, Circulating3
Pancreatic Neoplasms3
Breast Neoplasms2
Carcinoma, Renal Cell2

Trials

Showing 1 to 25 of 212. Each trial links to its page on Pharma Observatory.

112 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.